Gene–environmental interaction (G × E) between a common functional polymorphism in the promoter region of the serotonin transporter gene (5-HTT) and environmental adversity on the onset of depression in humans has been found in fifteen independent studies. It is supported by evidence from animal experiments, pharmacological challenge and neuroimaging investigations. However, negative findings have been reported in two large samples. We explore reasons for the inconsistencies and suggest means to their resolution. Sample age and gender composition emerge as important factors. While the G × E has been consistently detected in young adult samples, there are contradictory findings in adolescent boys and elderly people. The method of assessment of environmental adversity is also important with detailed interview-based approaches being associated with positive G × E findings. Unresolved issues in the definition of the genotype include the dominance of alleles and influence of other polymorphisms, both in 5-HTT and other genes. Assessment of multiple adverse outcomes, including depression, substance use and self-destructive behaviour is needed to clarify the generalisability of the G × E pathogenic mechanisms. Biological and behavioural intermediate phenotypes are yet to be exploited to understand the mechanisms underlying the G × E.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
McGuffin P, Riley B, Plomin R . Genomics and behavior. Toward behavioral genomics. Science 2001; 291: 1232–1249.
Boomsma DI, Martin NG . Gene–environment interactions. In: D’haenen HAH, den Boer JA, Wilner P (eds). Biological Psychiatry. John Wiley & Sons: New York, NY, 2002 pp 181–187.
Moffitt TE, Caspi A, Rutter M . Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 2005; 62: 473–481.
Eaves L, Silberg J, Erkanli A . Resolving multiple epigenetic pathways to adolescent depression. J Child Psychol Psychiatry 2003; 44: 1006–1014.
Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 1995; 152: 833–842.
Rice F, Harold GT, Thapar A . The effect of birth-weight with genetic susceptibility on depressive symptoms in childhood and adolescence. Eur Child Adolesc Psychiatry 2006; 15: 383–391.
Silberg J, Rutter M, Neale M, Eaves L . Genetic moderation of environmental risk for depression and anxiety in adolescent girls. Br J Psychiatry 2001; 179: 116–121.
Barr CS, Newman TK, Lindell S, Shannon C, Champoux M, Lesch KP et al. Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiatry 2004; 61: 1146–1152.
Bennett AJ, Lesch KP, Heils A, Long JC, Lorenz JG, Shoaf SE et al. Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry 2002; 7: 118–122.
Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851–854.
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389.
Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biol Psychiatry 2005; 57: 1117–1127.
Kahn RS, Khoury J, Nichols WC, Lanphear BP . Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr 2003; 143: 104–110.
Foley DL, Eaves LJ, Wormley B, Silberg JL, Maes HH, Kuhn J et al. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 2004; 61: 738–744.
Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B . The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62: 529–535.
Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, Craig IW et al. MAOA, maltreatment, and gene–environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 2006; 11: 903–913.
Jennings KA, Loder MK, Sheward WJ, Pei Q, Deacon RM, Benson MA et al. Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J Neurosci 2006; 26: 8955–8964.
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in serotonin transporter-deficient mice. Mol Pharmacol 1998; 53: 649–655.
Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL . Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 2003; 28: 2077–2088.
Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 2007; 27: 684–691.
Adamec R, Burton P, Blundell J, Murphy DL, Holmes A . Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 2006; 170: 126–140.
Li Q, Holmes A, Ma L, Van de Kar LD, Garcia F, Murphy DL . Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. J Neurosci 2004; 24: 10868–10877.
Tjurmina OA, Armando I, Saavedra JM, Goldstein DS, Murphy DL . Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 2002; 143: 4520–4526.
Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA . Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004; 306: 879–881.
Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL et al. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet 2006; 37: 214–222.
Barr CS, Newman TK, Shannon C, Parker C, Dvoskin RL, Becker ML et al. Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry 2004; 55: 733–738.
Champoux M, Bennett A, Shannon C, Higley JD, Lesch KP, Suomi SJ . Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol Psychiatry 2002; 7: 1058–1063.
Barr CS, Newman TK, Becker ML, Parker CC, Champoux M, Lesch KP et al. The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav 2003; 2: 336–340.
Jacobs N, Kenis G, Peeters F, Derom C, Vlietinck R, van OJ . Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry 2006; 63: 989–996.
Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci USA 2004; 101: 17316–17321.
Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006; 59: 673–680.
Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 2007 (doi:10.1016/j.biopsych.2006.11.020).
Mandelli L, Serretti A, Marino E, Pirovano A, Calati R, Colombo C . Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Int J Neuropsychopharmacol 2006; 1–11.
Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI . Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 2006; 60: 671–676.
Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 2006; 188: 210–215.
Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 2006; 163: 1588–1593.
Cervilla JA, Molina E, Rivera M, Torres-Gonzalez F, Bellon JA, Moreno B et al. The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-gene cohort. Mol Psychiatry 2007; 12: 748–755.
Nakatani D, Sato H, Sakata Y, Shiotani I, Kinjo K, Mizuno H et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 150: 652–658.
Scheid JM, Holzman CB, Jones N, Friderici KH, Nummy KA, Symonds LL et al. Depressive symptoms in mid-pregnancy, lifetime stressors and the 5-HTTLPR genotype. Genes Brain Behav 2007; 6: 453–464.
Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P et al. Gene–environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004; 9: 908–915.
Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2005; 10: 220–224.
Sjoberg RL, Nilsson KW, Nordquist N, Ohrvik J, Leppert J, Lindstrom L et al. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol 2006; 9: 443–449.
Covault J, Tennen H, Armeli S, Conner TS, Herman AI, Cillessen AH et al. Interactive effects of the serotonin transporter 5-HTTLPR polymorphism and stressful life events on college student drinking and drug use. Biol Psychiatry 2006; 61: 609–616.
Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG . The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med 2005; 35: 101–111.
Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J . Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry 2006; 59: 224–229.
Lenze EJ, Munin MC, Ferrell RE, Pollock BG, Skidmore E, Lotrich F et al. Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depression in elderly persons after hip fracture. Am J Geriatr Psychiatry 2005; 13: 428–432.
Gibb BE, McGeary JE, Beevers CG, Miller IW . Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide Life Threat Behav 2006; 36: 687–693.
Hardt J, Rutter M . Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J Child Psychol Psychiatry 2004; 45: 260–273.
Mannelli P, Patkar AA, Peindl K, Tharwani H, Gopalakrishnan R, Hill KP et al. Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. Psychiatry Res 2006; 144: 99–108.
Paykel ES . Stress and affective disorders in humans. Semin Clin Neuropsychiatry 2001; 6: 4–11.
Simon GE, VonKorff M . Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. Epidemiol Rev 1995; 17: 221–227.
Luan JA, Wong MY, Day NE, Wareham NJ . Sample size determination for studies of gene–environment interaction. Int J Epidemiol 2001; 30: 1035–1040.
Wong MY, Day NE, Luan JA, Chan KP, Wareham NJ . The detection of gene–environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol 2003; 32: 51–57.
Murphy JM, Laird NM, Monson RR, Sobol AM, Leighton AH . A 40-year perspective on the prevalence of depression: the Stirling county study. Arch Gen Psychiatry 2000; 57: 209–215.
Piccinelli M, Wilkinson G . Gender differences in depression. Critical review. Br J Psychiatry 2000; 177: 486–492.
Maciejewski PK, Prigerson HG, Mazure CM . Sex differences in event-related risk for major depression. Psychol Med 2001; 31: 593–604.
Silberg J, Pickles A, Rutter M, Hewitt J, Simonoff E, Maes H et al. The influence of genetic factors and life stress on depression among adolescent girls. Arch Gen Psychiatry 1999; 56: 225–232.
Cadoret RJ, Langbehn D, Caspers K, Troughton EP, Yucuis R, Sandhu HK et al. Associations of the serotonin transporter promoter polymorphism with aggressivity, attention deficit, and conduct disorder in an adoptee population. Compr Psychiatry 2003; 44: 88–101.
Nilsson KW, Sjoberg RL, Damberg M, Alm PO, Ohrvik J, Leppert J et al. Role of the serotonin transporter gene and family function in adolescent alcohol consumption. Alcohol Clin Exp Res 2005; 29: 564–570.
Silberg J, Rutter M, D’Onofrio B, Eaves L . Genetic and environmental risk factors in adolescent substance use. J Child Psychol Psychiatry 2003; 44: 664–676.
Kendler KS, Thornton LM, Gardner CO . Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the ‘kindling’ hypothesis. Am J Psychiatry 2000; 157: 1243–1251.
Kendler KS, Gatz M, Gardner CO, Pedersen NL . Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry 2006; 63: 1113–1120.
Meltzer H . Serotonergic dysfunction in depression. Br J Psychiatry Suppl 1989; 155: 25–31.
Goodnick PJ, Goldstein BJ . Selective serotonin reuptake inhibitors in affective disorders—I. Basic pharmacology. J Psychopharmacol 1998; 12: S5–S20.
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR . Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47: 411–418.
Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 1994; 95: 157–162.
Gelernter J, Freimer M . PstI RFLP at the SERT locus. Hum Mol Genet 1994; 3: 383.
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624.
Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK . Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 1999; 88: 61–66.
Bradley SL, Dodelzon K, Sandhu HK, Philibert RA . Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 2005; 136: 58–61.
Glatz K, Mossner R, Heils A, Lesch KP . Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promotor-linked polymorphic region. J Neurochem 2003; 86: 1072–1078.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.
Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 2004; 55: 1090–1094.
Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 2006; 163: 48–51.
Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643–649.
Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL . Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83–87.
Shioe K, Ichimiya T, Suhara T, Takano A, Sudo Y, Yasuno F et al. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 2003; 48: 184–188.
Willeit M, Stastny J, Pirker W, Praschak-Rieder N, Neumeister A, Asenbaum S et al. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry 2001; 50: 8–12.
van Dyck CH, Malison RT, Staley JK, Jacobsen LK, Seibyl JP, Laruelle M et al. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry 2004; 161: 525–531.
Lim JE, Papp A, Pinsonneault J, Sadee W, Saffen D . Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol Psychiatry 2006; 11: 649–662.
Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155: 207–213.
Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000; 57: 729–738.
Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ et al. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003; 28: 533–541.
Jonsson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Res 1998; 79: 1–9.
David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R et al. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005; 25: 2586–2590.
Reist C, Mazzanti C, Vu R, Tran D, Goldman D . Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet 2001; 105: 363–368.
Smith GS, Lotrich FE, Malhotra AK, Lee AT, Ma Y, Kramer E et al. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 2004; 29: 2226–2234.
Whale R, Quested DJ, Laver D, Harrison PJ, Cowen PJ . Serotonin transporter (5-HTT) promotor genotype may influence the prolactin response to clomipramine. Psychopharmacology 2000; 150: 120–122.
Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J et al. Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 2002; 7: 213–216.
Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O et al. Differential effects of 5-HTTLPR Genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 2006; 63: 978–986.
Finger EC, Marsh AA, Buzas B, Kamel N, Rhodes R, Vythilingham M et al. The impact of tryptophan depletion and 5-HTTLPR genotype on passive avoidance and response reversal instrumental learning tasks. Neuropsychopharmacology 2007; 32: 206–215.
Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 2002; 59: 613–620.
Roiser JP, Blackwell AD, Cools R, Clark L, Rubinsztein DC, Robbins TW et al. Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology 2006; 31: 2264–2272.
Roiser JP, Muller U, Clark L, Sahakian BJ . The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. Int J Neuropsychopharmacol 2007; 10: 449–461.
Bertolino A, Arciero G, Rubino V, Latorre V, De CM, Mazzola V et al. Variation of human amygdala response during threatening stimuli as a function of 5′HTTLPR genotype and personality style. Biol Psychiatry 2005; 57: 1517–1525.
Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF et al. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005; 62: 146–152.
Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002; 297: 400–403.
Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8: 20–21.
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al. 5-HTTLPR polymorphism impacts human cingulate–amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828–834.
Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP . Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci USA 2005; 102: 12224–12229.
Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 2006; 61: 1011–1014.
Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z et al. Neural correlates of epigenesis. Proc Natl Acad Sci USA 2006; 103: 16033–16038.
Brocke B, Armbruster D, Muller J, Hensch T, Jacob CP, Lesch KP et al. Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Mol Psychiatry 2006; 11: 1106–1112.
Nakamura M, Ueno S, Sano A, Tanabe H . The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000; 5: 32–38.
Kraft JB, Slager SL, McGrath PJ, Hamilton SP . Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 2005; 58: 374–381.
Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive–compulsive disorder. Am J Hum Genet 2006; 78: 815–826.
Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL . Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 2006; 11: 224–226.
Martin J, Cleak J, Willis-Owen SA, Flint J, Shifman S . Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol Psychiatry 2007; 12: 421–422.
Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN . Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2003; 2: 365–380.
Kalueff AV, Ren-Patterson RF, Murphy DL . The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends Pharmacol Sci 2007; 28: 122–127.
Smeraldi E, Zanardi R, Benedetti F, Di BD, Perez J, Catalano M . Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998; 3: 508–511.
Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L . 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol 2003; 23: 563–567.
Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E et al. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry 2001; 50: 323–330.
Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 2000; 11: 215–219.
Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C et al. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 2005; 49: 798–810.
Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ et al. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 2006; 61: 734–742.
Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000; 23: 587–590.
Zanardi R, Benedetti F, Di BD, Catalano M, Smeraldi E . Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 2000; 20: 105–107.
Aitchison K, Huezo-Diaz P, Williamson R, Hoda F, Nash M, Rietschel M et al. Genetic association data from GENDEP, a multicentre European study. Am J Med Genet Part B 2006; 141B: 690.
Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96: 15239–15244.
Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T et al. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 2005; 79: 756–771.
Ren-Patterson RF, Cochran LW, Holmes A, Lesch KP, Lu B, Murphy DL . Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cell Mol Neurobiol 2006; 26: 753–778.
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257–269.
Gratacos M, Gonzalez JR, Mercader JM, Cid RD, Urretavizcaya M, Estivill X . Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case–control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007; 61: 911–922.
Genes and Environment Initiative (GEI) http://www.gei.nih.gov. 2007; Accessed 06/06/2007.
Brown GW, Harris TO . Social origins of depression. A Study of Psychiatric Disorder in Women, 5 edn. Routledge: London, 1978.
Holmes TH, Rahe RH . The social readjustment rating scale. J Psychosom Res 1967; 11: 213–218.
Kendler KS, Karkowski LM, Prescott CA . Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999; 156: 837–841.
Kendler KS, Karkowski LM, Prescott CA . Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J Nerv Ment Dis 1998; 186: 661–669.
Wainwright NW, Surtees PG . Time-varying exposure and the impact of stressful life events on onset of affective disorder. Stat Med 2002; 21: 2077–2091.
Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA . Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry 2003; 60: 789–796.
Clark DB, Lesnick L, Hegedus AM . Traumas and other adverse life events in adolescents with alcohol abuse and dependence. J Am Acad Child Adolesc Psychiatry 1997; 36: 1744–1751.
Schmidt U, Tiller J, Blanchard M, Andrews B, Treasure J . Is there a specific trauma precipitating anorexia nervosa? Psychol Med 1997; 27: 523–530.
Bebbington P, Wilkins S, Jones P, Foerster A, Murray R, Toone B et al. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993; 162: 72–79.
Cohen LH, Towbes LC, Flocco R . Effects of induced mood on self-reported life events and perceived and received social support. J Pers Soc Psychol 1988; 55: 669–674.
Paykel ES . The Interview for Recent Life Events. Psychol Med 1997; 27: 301–310.
Surtees PG, Wainwright NW . Surviving adversity: event decay, vulnerability and the onset of anxiety and depressive disorder. Eur Arch Psychiatry Clin Neurosci 1999; 249: 86–95.
Pine DS, Cohen P, Johnson JG, Brook JS . Adolescent life events as predictors of adult depression. J Affect Disord 2002; 68: 49–57.
Kendler KS, Neale M, Kessler R, Heath A, Eaves L . A twin study of recent life events and difficulties. Arch Gen Psychiatry 1993; 50: 789–796.
Kendler KS, Karkowski-Shuman L . Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychol Med 1997; 27: 539–547.
Krueger RF, Markon KE, Bouchard Jr TJ . The extended genotype: the heritability of personality accounts for the heritability of recalled family environments in twins reared apart. J Pers 2003; 71: 809–833.
Plomin R, Lichtenstein P, Pedersen NL, McClearn GE, Nesselroade JR . Genetic influence on life events during the last half of the life span. Psychol Aging 1990; 5: 25–30.
Kessler RC, Magee WJ . Childhood adversities and adult depression: basic patterns of association in a US national survey. Psychol Med 1993; 23: 679–690.
van Os J, Jones PB . Early risk factors and adult person–environment relationships in affective disorder. Psychol Med 1999; 29: 1055–1067.
Kendler KS, Karkowski LM, Prescott CA . The assessment of dependence in the study of stressful life events: validation using a twin design. Psychol Med 1999; 29: 1455–1460.
Kendler KS, Gardner CO, Prescott CA . Personality and the experience of environmental adversity. Psychol Med 2003; 33: 1193–1202.
Munafo MR, Clark T, Flint J . Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits. A meta-analysis. Mol Psychiatry 2005; 10: 415–419.
Schinka JA, Busch RM, Robichaux-Keene N . A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 2004; 9: 197–202.
Sen S, Burmeister M, Ghosh D . Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004; 127: 85–89.
Loehlin JC . Genes and environment in personality development. Sage: Newbury Park, CA, 1992.
Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT . Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet 2005; 133B: 110–115.
Kaufman J, Yang BZ, Douglas-Palumberi H, Crouse-Artus M, Lipschitz D, Krystal JH et al. Genetic and environmental predictors of early alcohol use. Biol Psychiatry 2007; 61: 1228–1234.
Reif A, Rosler M, Freitag CM, Schneider M, Eujen A, Kissling C et al. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology 2007 (doi:10.1038/sj.npp.1301359).
Barr CS, Newman TK, Becker ML, Champoux M, Lesch KP, Suomi SJ et al. Serotonin transporter gene variation is associated with alcohol sensitivity in rhesus macaques exposed to early-life stress. Alcohol Clin Exp Res 2003; 27: 812–817.
Li D, He L . Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007; 12: 47–54.
Bondy B, Buettner A, Zill P . Genetics of suicide. Mol Psychiatry 2006; 11: 336–351.
Gorwood P, Batel P, Ades J, Hamon M, Boni C . Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 2000; 48: 259–264.
Feinn R, Nellissery M, Kranzler HR . Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 2005; 133: 79–84.
Nellissery M, Feinn RS, Covault J, Gelernter J, Anton RF, Pettinati H et al. Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. Alcohol Clin Exp Res 2003; 27: 1402–1408.
Gottesman II, Gould TD . The endophenotype concept in psychiatry: etimology and strategic intentions. Am J Psychiatry 2003; 160: 636–645.
Nolen-Hoeksema S . The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J Abnorm Psychol 2000; 109: 504–511.
Kernis MH, Cornell DP, Sun CR, Berry A, Harlow T . There's more to self-esteem than whether it is high or low: the importance of stability of self-esteem. J Pers Soc Psychol 1993; 65: 1190–1204.
Kashdan TB, Barrios V, Forsyth JP, Steger MF . Experiential avoidance as a generalized psychological vulnerability: comparisons with coping and emotion regulation strategies. Behav Res Ther 2006; 44: 1301–1320.
Lejuez CW, Aklin WM, Zvolensky MJ, Pedulla CM . Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours. J Adolesc 2003; 26: 475–479.
Holliday J, Tchanturia K, Landau S, Collier D, Treasure J . Is impaired set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry 2005; 162: 2269–2275.
Bechara A, Damasio H, Tranel D, Damasio AR . Deciding advantageously before knowing the advantageous strategy. Science 1997; 275: 1293–1295.
Verona E, Joiner TE, Johnson F, Bender TW . Gender specific gene–environment interactions on laboratory-assessed aggression. Biol Psychol 2006; 71: 33–41.
Beevers CG, Gibb BE, McGeary JE, Miller IW . Serotonin transporter genetic variation and biased attention for emotional word stimuli among psychiatric inpatients. J Abnorm Psychol 2007; 116: 208–212.
Caspi A, Moffitt TE . Gene–environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006; 7: 583–590.
Eaves LJ . Genotype × environment interaction in psychopathology: fact or artifact? Twin Res Hum Genet 2006; 9: 1–8.
Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruc L, Nothen MM et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet 2004; 12: 377–382.
Devlin B, Roeder K, Bacanu SA . Unbiased methods for population-based association studies. Genet Epidemiol 2001; 21: 273–284.
We would like to thank Avshalom Caspi and Terrie Moffitt for their helpful comments on previous versions of the manuscript.
About this article
Cite this article
Uher, R., McGuffin, P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13, 131–146 (2008). https://doi.org/10.1038/sj.mp.4002067
- gene–environment interaction
- substance abuse
- serotonin transporter
- stressful life events
Genome-wide stress sensitivity moderates the stress-depression relationship in a nationally representative sample of adults
Scientific Reports (2021)
Journal of Neural Transmission (2021)
Triple jeopardy: the joint impact of racial segregation and neighborhood poverty on the mental health of black Americans
Social Psychiatry and Psychiatric Epidemiology (2019)
Molecular Psychiatry (2018)
ADHD Symptoms in Middle Adolescence Predict Exposure to Person-Related Life Stressors in Late Adolescence in 5-HTTLPR S-allele Homozygotes
Journal of Abnormal Child Psychology (2018)